HEAL Act of 2023

S 2809, the HEAL Act of 2023, requires the Department of Health and Human Services (HHS) to update federal grant program regulations related to opioid misuse. It mandates that references to "opioid overdose reversal agents" in HHS guidance and grants - specifically for State Opioid Response and Tribal Opioid Response Grants - must include *any* FDA-approved drug or device for emergency opioid overdose treatment, not just naloxone. This change, effective by December 31, 2023, ensures states and tribes can use federal funds for a broader range of approved overdose reversal products. The bill directly affects HHS grant programs administered under the 21st Century Cures Act and the Public Health Service Act.